Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BSP Pharmaceuticals provides integrated development and manufacturing services for cytotoxic and high-potent oncology drugs as well as non-cytotoxic innovative compounds. The company operates two segregated facilities with advanced containment technologies to support the full product lifecycle from preclinical through commercial stages. It specializes in handling both small molecules and complex biologics such as ADCs, peptides, proteins, oligonucleotides, and nanomedicines. Its facilities are approved by major regulatory authorities including EMA and FDA. As a CDMO/CMO, it does not publish clinical results or maintain an internal drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BSP Pharmaceuticals.